USDA ReConnect Round 5 Application Workshops

The USDA Rural Development Rural Utilities Service (RUS) is providing a three-day workshop for those interested in applying for ReConnect Program funding. The ReConnect Program offers loans, grants, and loan/grant combinations to facilitate broadband deployment in areas of rural America without sufficient access to broadband. To learn more about the ReConnect Program, please visit: https://www.usda.gov/reconnect.

The workshop will take place in-person at Silver Legacy located at 407 N. Virgina Street, Reno, NV.

The three-day workshop will provide attendees with an understanding of the ReConnect program application system and program requirements for FY2024. Topics will include:

  • Program Eligibility
  • Live Demonstrations of the Application System
  • Evaluation Criteria
  • Overview and deep dive sessions on financial, network, environmental, and mapping requirements

Dates and Times

  • February 27-29, 2024
  • Tuesday, February 27th, 8:30 a.m.- 5:30 p.m.
  • Wednesday, February 28th, 8:30 a.m.- 5:00 p.m.
  • Thursday, February 29th, 8:30 a.m.- 12:00 p.m.

Register Here!

Please Note: Registration should only be submitted once and is not required for each day. After registering you will not receive an email confirmation. The workshop agenda is now available and has been posted to the Events Page on the ReConnect website.

Contact

Please submit any ReConnect questions using the Contact Us Form on the ReConnect website.

USDA ReConnect Program Webinar: Round 5 Preparing to Apply

We added an additional webinar for those who could not previously attend. No new information will be provided.

Presented by USDA Rural Development’s Rural Utilities Service, the webinar will provide information about the ReConnect Program and help prepare applicants ahead of the next Notice of Funding Opportunity (NOFO).

This webinar will include:

  • What applicants can do now to prepare for the next NOFO.
  • Registration and system requirements.
  • A high-level look at ReConnect Program eligibility requirements.
  • Tips on using the Application System.
  • An opportunity to ask RUS staff questions about the application preparation.

We’ll address as many questions as time permits during each session. Once the NOFO is published, RUS will host a NOFO Overview webinar and include an updated list of the most common questions on our frequently asked questions page on the ReConnect website.

Date and Time:

February 7, 2024 from 1:00 PM-2:30 PM EST

Register Here

Contact

If you have questions after the event, please submit them using Contact Us.

HHS Finalizes Rule on Telehealth at Opioid Treatment Programs

From Healthcare Dive

The rule marks the first substantial changes to treatment and delivery standards at opioid treatment programs in more than 20 years, the government said.

Dive Brief:

  • The HHS on Thursday finalized a rule that will allow opioid treatment programs to begin some medication treatment via telehealth.
  • Under the rule, these providers will be able to initiate treatment with buprenorphine through audio-only or audio-visual telehealth. They can begin methadone treatment via an audio-visual platform — but not through an audio-only option due to its higher risk profile, the Substance Abuse and Mental Health Services Administration said.
  • The regulation makes permanent telehealth flexibilities that began during the COVID-19 pandemic to preserve access to care and tackle a worsening opioid epidemic.

Dive Insight:

The rule marks the first substantial changes to treatment and delivery standards at opioid treatment programs in more than 20 years, SAMHSA said.

The updates — which also include expanding eligibility for patients to receive take-home doses of methadone and allowing more provider types to order medications — aim to reduce stigma and expand care access, which can be challenges to treating people with substance use disorders.

Telehealth could be a significant aid on that front, experts say. Virtual care use soared during the COVID pandemic, helped by loosened regulations that allowed patients to receive care while maintaining social distance.

Some research has shown telehealth can expand who can access mental healthcare and opioid use disorder treatment, potentially preventing overdoses. Provisional data suggests drug overdose deaths reached nearly 107,000 during the 12 months ending in August 2023, according to the Centers for Disease Control and Prevention.

“While this rule change will help anyone needing treatment, it will be particularly impactful for those in rural areas or with low income for whom reliable transportation can be a challenge, if not impossible,” Miriam Delphin-Rittmon, the HHS assistant secretary for mental health and substance use, said in a statement.

Regulators have made other changes that could improve access to substance use disorder treatment. During the pandemic, the Drug Enforcement Administration granted exceptions to the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, which required most practitioners to have at least one in-person evaluation before prescribing controlled substances.

The DEA and the HHS announced in the fall that they would extend pandemic-era prescribing rules through 2024. Advocates cheered the extension, arguing in-person requirements limited access, particularly for opioid use disorder care.

Information Released on How to Use the Office & Outpatient Evaluation and Management Visit Complexity Add-on Code G2211

The Centers for Medicare & Medicaid Services (CMS) released guidance for the implementation of the Office & Outpatient (O/O) Evaluation and Management (E/M) visit complexity add-on code G2211 beginning January 1, 2024. Included in the guidance are the documentation requirements for G2211, the correct use of the code and modifier 25, and patient coinsurance and deductible.

Read the full article here.

New Guidance on Billing Requirements for Intensive Outpatient Program Services for Federally Qualified Health Centers & Rural Health Clinics

Starting January 1, 2024, Medicare began coverage and payment for Intensive Outpatient Program (IOP) services that Federally Qualified Health Centers (FQHCs) and Rural Health Clinics (RHCs) provide for people with mental health needs. An IOP is a distinct and organized outpatient program of psychiatric services provided for patients with acute mental illness including, but not limited to, conditions such as depression, schizophrenia, and substance use disorder. The Centers for Medicare & Medicaid Services (CMS) will pay for IOP services provided at the same payment rate as those paid to hospitals. Additional information on IOP services including scope of benefits, certification and plan of care requirements, payment policies, and coding and billing requirements is included in the recent CMS guidance.

Read the full article here.

CMS Requesting Information on Medicare Advantage Data

The Centers for Medicare & Medicaid Services (CMS) seeks feedback on how best to enhance Medicare Advantage (MA) data capabilities and increase public transparency.  With over half of Medicare beneficiaries, and 45 percent of rural beneficiaries, enrolled in MA, transparency about the program has become increasingly important.  In this request for information, CMS is seeking detailed information on common challenges and experiences in the MA program for which limited data are currently available.  Feedback may include data-related recommendations related to beneficiary access to care; prior authorization and utilization management strategies; cost and utilization of supplemental benefits; all aspects of MA marketing and consumer decision-making; care quality and outcomes; health equity; market competition; and special populations, such as individuals dually eligible for Medicare and Medicaid and other enrollees with complex conditions. They encourage input from beneficiaries and beneficiary advocates, plans, providers, community-based organizations, researchers, employers and unions, and the public at large.

Comment by May 29.

Read the full article here.